Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Apr;80(4):337–342. doi: 10.1136/bjo.80.4.337

Onchocerciasis in Ecuador: evolution of chorioretinopathy after amocarzine treatment.

P J Cooper 1, R Proaño 1, C Beltran 1, M Anselmi 1, R H Guderian 1
PMCID: PMC505461  PMID: 8703886

Abstract

AIMS: To investigate the impact of the macrofilaricidal drug, amocarzine, on the evolution of chorioretinopathy in onchocerciasis. METHODS: A prospective uncontrolled cohort study was performed using subjects infected with Onchocerca volvulus in a hyperendemic onchocerciasis focus in Esmeraldas Province in Ecuador. Study subjects were recruited into four cohorts in which ophthalmic and parasitological data were collected for 2, 3, 4, and 5 years respectively. RESULTS: Complete ophthalmic follow up was obtained for 294 individuals in the four cohorts. The incidence of retinal pigment epithelial atrophy tended to remain constant between cohorts while that of chorioretinal scarring with a greater observation period. The incidence rate of cases with new or extending chorioretinal lesions was greater with an increasing period of follow up. An association was seen between the cumulative microfilarial loads in the skin and the development of new chorioretinal lesions (p < 0.05). No relation was noted between cumulative microfilarial loads and the progression of existing disease. CONCLUSION: Amocarzine therapy did not prevent the natural evolution of chorioretinal disease. It was suggested that ocular microfilariae were necessary for the induction of chorioretinopathy in previously unaffected eyes and that extension of existing disease might also be related to the presence of ocular microfilariae or to other immunological mechanisms.

Full text

PDF
337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abiose A., Murdoch I., Babalola O., Cousens S., Liman I., Onyema J., Evans J., Gregory W., Jones B. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol. 1994 Jan;78(1):8–13. doi: 10.1136/bjo.78.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson J., Fuglsang H. Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin. Br J Ophthalmol. 1978 Jul;62(7):450–457. doi: 10.1136/bjo.62.7.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson J., Fuglsang H., Marshall T. F., Radolowicz A., Vaughan J. P. Studies on onchocerciasis in the United Cameroon Republic. IV. A four-year follow-up of six rain-forest and six savanna villages. The incidence of ocular lesions. Trans R Soc Trop Med Hyg. 1978;72(5):513–515. doi: 10.1016/0035-9203(78)90172-4. [DOI] [PubMed] [Google Scholar]
  4. Anderson J., Fuglsang H., Marshall T. F. Studies on onchocerciasis in the United Cameroon Republic. III. A four year follow-up of 6 rain-forest and 6 Sudan-savanna villages. Trans R Soc Trop Med Hyg. 1976;70(5-6):362–373. doi: 10.1016/0035-9203(76)90112-7. [DOI] [PubMed] [Google Scholar]
  5. Anderson J., Fuglsang H., de C Marshall T. F. Effects of diethylcarbamazine on ocular onchocerciasis. Tropenmed Parasitol. 1976 Sep;27(3):263–278. [PubMed] [Google Scholar]
  6. Anderson J., Fuglsang H., de C Marshall T. F. Effects of suramin on ocular onchocerciasis. Tropenmed Parasitol. 1976 Sep;27(3):279–296. [PubMed] [Google Scholar]
  7. Bird A. C., Anderson J., Fuglsang H. Morphology of posterior segment lesions of the eye in patients with onchocerciasis. Br J Ophthalmol. 1976 Jan;60(1):2–20. doi: 10.1136/bjo.60.1.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bird A. C., el-Sheikh H., Anderson J., Fuglsang H. Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. Br J Ophthalmol. 1980 Mar;64(3):191–200. doi: 10.1136/bjo.64.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Braun G., McKechnie N. M., Connor V., Gilbert C. E., Engelbrecht F., Whitworth J. A., Taylor D. W. Immunological crossreactivity between a cloned antigen of Onchocerca volvulus and a component of the retinal pigment epithelium. J Exp Med. 1991 Jul 1;174(1):169–177. doi: 10.1084/jem.174.1.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Budden F. H. The natural history of ocular onchocerciasis over a period of 14--15 years and the effect on this of a single course of suramin therapy. Trans R Soc Trop Med Hyg. 1976;70(5-6):484–491. doi: 10.1016/0035-9203(76)90134-6. [DOI] [PubMed] [Google Scholar]
  11. Cooper P. J., Proaño R., Beltran C., Anselmi M., Guderian R. H. Onchocerciasis in Ecuador: ocular findings in Onchocerca volvulus infected individuals. Br J Ophthalmol. 1995 Feb;79(2):157–162. doi: 10.1136/bjo.79.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dadzie K. Y., Remme J., Alley E. S., de Sole G. Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus. Trans R Soc Trop Med Hyg. 1990 Jan-Feb;84(1):103–108. doi: 10.1016/0035-9203(90)90395-u. [DOI] [PubMed] [Google Scholar]
  13. Dadzie K. Y., Remme J., De Sole G. Epidemiological impact of vector control. II. Changes in ocular onchocerciasis. Acta Leiden. 1990;59(1-2):127–139. [PubMed] [Google Scholar]
  14. Dadzie K. Y., Remme J., Rolland A., Thylefors B. The effect of 7-8 years of vector control on the evolution of ocular onchocerciasis in West African savanna. Trop Med Parasitol. 1986 Sep;37(3):263–270. [PubMed] [Google Scholar]
  15. Doft B. H., Gass J. D. Outer retinal layer toxoplasmosis. Graefes Arch Clin Exp Ophthalmol. 1986;224(1):78–82. doi: 10.1007/BF02144142. [DOI] [PubMed] [Google Scholar]
  16. Friedmann C. T., Knox D. L. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 1969 Apr;81(4):481–493. doi: 10.1001/archopht.1969.00990010483005. [DOI] [PubMed] [Google Scholar]
  17. Fuglsang H., Anderson J. Further observations on the relationship between ocular onchocerciasis and the head nodule, and on the possible benefit of nodulectomy. Br J Ophthalmol. 1978 Jul;62(7):445–449. doi: 10.1136/bjo.62.7.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fuglsang H., Anderson J., de C Marshall T. F. The head nodule and ocular onchocerciasis in Africa. Tropenmed Parasitol. 1976 Sep;27(3):355–364. [PubMed] [Google Scholar]
  19. Guderian R. H., Anselmi M., Proaño R., Naranjo A., Poltera A. A., Moran M., Lecaillon J. B., Zak F., Cascante S. Onchocercacidal effect of three drug regimens of amocarzine in 148 patients of two races and both sexes from Esmeraldas, Ecuador. Trop Med Parasitol. 1991 Sep;42(3):263–285. [PubMed] [Google Scholar]
  20. Guderian R. H., Beck B. J., Proano J. R., Mackenzie C. D. Onchocerciasis in Ecuador, 1980-1986: epidemiological evaluation of the disease in the Esmeraldas province. Eur J Epidemiol. 1989 Sep;5(3):294–302. doi: 10.1007/BF00144829. [DOI] [PubMed] [Google Scholar]
  21. Guderian R. H., Beck B. J., Proaño R. Onchocerciasis in Ecuador: infection in children in the Santiago Basin focus, province of Esmeraldas. Trans R Soc Trop Med Hyg. 1990 Jan-Feb;84(1):109–112. doi: 10.1016/0035-9203(90)90396-v. [DOI] [PubMed] [Google Scholar]
  22. Guderian R. H., Leon L. A., Leon R., Corral F., Vasconez C., Johnston T. S. Report on a focus of onchocerciasis in Esmeraldas province of Ecuador. Am J Trop Med Hyg. 1982 Mar;31(2):270–274. doi: 10.4269/ajtmh.1982.31.270. [DOI] [PubMed] [Google Scholar]
  23. Guderian R. H., Shelley A. J. Onchocerciasis in Ecuador: the situation in 1989. Mem Inst Oswaldo Cruz. 1992 Jul-Sep;87(3):405–415. doi: 10.1590/s0074-02761992000300011. [DOI] [PubMed] [Google Scholar]
  24. McKechnie N. M., Braun G., Connor V., Kläger S., Taylor D. W., Alexander R. A., Gilbert C. E. Immunologic cross-reactivity in the pathogenesis of ocular onchocerciasis. Invest Ophthalmol Vis Sci. 1993 Sep;34(10):2888–2902. [PubMed] [Google Scholar]
  25. Newland H. S., White A. T., Greene B. M., Murphy R. P., Taylor H. R. Ocular manifestations of onchocerciasis in a rain forest area of west Africa. Br J Ophthalmol. 1991 Mar;75(3):163–169. doi: 10.1136/bjo.75.3.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. RODGER F. C. The pathogenesis and pathology of ocular on-chocerciasis. Part IV. The pathology. Am J Ophthalmol. 1960 Mar;49:560–594. doi: 10.1016/0002-9394(60)91658-5. [DOI] [PubMed] [Google Scholar]
  27. Rolland A., Thylefors B., Pairault C. Evolution sur neuf ans de l'onchocercose oculaire dans une communauté villageoise d'Afrique occidentale. Bull World Health Organ. 1978;56(5):805–810. [PMC free article] [PubMed] [Google Scholar]
  28. Rothova A., Van der Lelij A., Stilma J. S., Klaassen-Broekema N., Wilson W. R., Barbe R. F. Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin. Am J Ophthalmol. 1990 Jul 15;110(1):6–16. doi: 10.1016/s0002-9394(14)76930-2. [DOI] [PubMed] [Google Scholar]
  29. Semba R. D., Murphy R. P., Newland H. S., Awadzi K., Greene B. M., Taylor H. R. Longitudinal study of lesions of the posterior segment in onchocerciasis. Ophthalmology. 1990 Oct;97(10):1334–1341. doi: 10.1016/s0161-6420(90)32413-2. [DOI] [PubMed] [Google Scholar]
  30. Soula G., Pichard E., Doumbo O., Soula E., Poltera A. A., Striebel H. P. Activity of thiocarbamazine in patients dually infected with Schistosoma and Onchocerca volvulus. Lancet. 1989 Apr 1;1(8640):726–726. doi: 10.1016/s0140-6736(89)92240-x. [DOI] [PubMed] [Google Scholar]
  31. Taylor H. R., Murphy R. P., Newland H. S., White A. T., D'Anna S. A., Keyvan-Larijani E., Aziz M. A., Cupp E. W., Greene B. M. Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine. Arch Ophthalmol. 1986 Jun;104(6):863–870. doi: 10.1001/archopht.1986.01050180097039. [DOI] [PubMed] [Google Scholar]
  32. Thylefors B. Ocular onchocerciasis. Bull World Health Organ. 1978;56(1):63–73. [PMC free article] [PubMed] [Google Scholar]
  33. Van der Lelij A., Rothova A., Stilma J. S., Vetter J. C., Hoekzema R., Kijlstra A. Humoral and cell-mediated immune response against human retinal antigens in relation to ocular onchocerciasis. Acta Leiden. 1990;59(1-2):271–283. [PubMed] [Google Scholar]
  34. Zea-Flores G., Beltranena F., Poltera A. A., Lopez M., Moran M., Zea-Flores C. E., de Ramirez I., Lecaillon J. B., Zak F., Palomo M. Amocarzine investigated as oral onchocercacidal drug in 272 adult male patients from Guatemala. Results from three dose regimens spread over three days. Trop Med Parasitol. 1991 Sep;42(3):240–262. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES